CDKN2A and adenoma: Throughout the process of gastric carcinogenesis, the frequency of CDKN2A methylation increases significantly, ranging from noncancerous dysplasia (4%) or adenoma (18%) to cancer‐associated dysplasia or adenoma (29%), ultimately leading to the development of gastric adenocarcinoma (44%).